Michelle Dolan, M.D.

Assistant Professor
612-273-5934
dolan009@umn.edu

Educational Background

• College of St. Catherine, Minnesota (1986), B.A. (English)
• University of Minnesota Medical School, Minnesota (1993), M.D.

Professional Background

• Intern, University of Minnesota, Department of Internal Medicine, Minneapolis, MN, 1994 – 1995
• Resident, University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, MN, 1995 – 1999
• Chief Resident, University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, MN, 1999 – 2000
• Joint Fellowship in Cytogenetics and Molecular Diagnostics, University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, MN, 1999 – 2002
• Pathology Laboratory Instructor, University of Minnesota Medical School, Minneapolis, MN, 1995 – 1999
• Pathology Laboratory Review Instructor, University of Minnesota Medical School, Minneapolis, MN, 1997 – 1999
• Lecturer, University of Minnesota Medical School, Minneapolis, MN, 1998 – present
• Lecturer, University of Minnesota, Dental School, Minneapolis, MN, 1999 – present
• Assistant Professor, University of Minnesota Medical School, Department of Laboratory Medicine and Pathology, Minneapolis, MN, Current
• Assistant Director, University of Minnesota Medical Center, Fairview and University of Minnesota Outreach Laboratories, Cytogenetics Laboratory, Minneapolis, MN, Current
• Assistant Director, University of Minnesota Medical Center, Fairview and University of Minnesota Outreach Laboratories, Molecular Diagnostics Laboratory, Minneapolis, MN, Current

Board Certifications

• Minnesota State Medical Licensure
• American Board of Pathology, Anatomic Clinical Pathology, 2001
• American Board of Medical Genetics, Clinical Cytogenetics and Clinical Molecular Genetics, 2002

Professional Memberships

• College of American Pathologists
• American Society of Clinical Pathologists
• American Society of Human Genetics
• Association for Molecular Pathology

Professional Honors

• Phi Beta Kappa, 1985
• Kappa Gamma Pi, 1986
• St. Paul Court of Honor, 1986
• Who’s Who Among Students in American Colleges and Universities
• Alpha Omega Alpha, 1993
• Janet M. Glasgow Memorial Achievement Award, 1993

Publications

• Dolan M, Neglia J, McGlennen R, Hirsch B.  A novel, cryptic (X;11) insertion involving MLL in a child with AML.  American Society of Human Genetics, annual meeting, 1998.
• Dolan M, Wick M.  Clinical Applications of Cytogenetics and Molecular Diagnostics.  Minnesota Collaborative Spring Meeting of Laboratory Professionals, 2000 and 2001.
• Nakajima H, Zhao R, Lund TC, Ward J, Dolan M, Hirsch B, Miller JS. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients. Journal of Immunology 168(2):643-50, 2002.
• Dolan M, McGlennen RC, Hirsch B.  MLL amplification in myeloid malignancies: clinical, molecular and cytogenetic findings. Cancer Genetics and Cytogenetics 134(2):93-101, 2002.
• McKenna D, Rupp C, Wagner J, McGlennen R, Hirsch B, Dolan M, Burger SR, Hanson MN, Jaszcz W, Nguyen PL. Increased lymphoblast-like cells following umbilical cord blood stem cell transplantation do not predict recurrent acute leukemia. Leukemia 16(10):2171-2, 2002.
• Xu Y, Dolan MM, Nguyen PL. Diagnostic significance of detecting dysgranulopoiesis in chronic myeloid leukemia. American Journal of Clinical Pathology 120:778-784, 2003.
• Hirsch B, Dolan M, Brandt K, MacMillan ML, Wagner J, Johari V, Nguyen P.  Recurring clonal chromosomal abnormalities in Fanconi anemia: characterization and association with bone marrow pathology. Fifteenth Annual Fanconi Anemia Research Fund Scientific Symposium, October 2003.
• Dolan M, Seibel MM, Brown CA. Novel BCR-ABL fusion transcript with complex cytogenetic abnormalities in a case of relapsed chronic myeloid leukemia. Academy of Clinical Laboratory Physicians and Scientists (ACLPS) Annual Meeting, June 2003.
• Dolan M, Snover D. Comparison of immunohistochemical and fluorescence in-situ hybridization assessment of HER2 status in routine practice. Academy of Clinical Laboratory Physicians and Scientists (ACLPS) Annual Meeting, June 2003.
• Dolan M, Jessurun J, Hirsch B. Cytogenetic abnormalities in posttransplant lymphoproliferative disorders. Academy of Clinical Laboratory Physicians and Scientists (ACLPS) Annual Meeting, June 2003.
• Dolan M, Hirsch B, Mascotti K, Simonton S. Distinct clonal abnormalities in different histologic components of a Wilms tumor. Academy of Clinical Laboratory Physicians and Scientists (ACLPS) Annual Meeting, June 2003.
• Dolan M and Mascotti K. Cytogenetically unrelated clones in different histologic components of a Wilms tumor. Cancer Genetics and Cytogenetics 159(1):63-8, 2005.
• Dolan M and Snover D. Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice. American Journal of Clinical Pathology 123(5):766-70, 2005.
• Peters A, Manivel JC, Dolan M, Baker KS, Verneris MR. Pulmonary cytolytic thrombi: a further histologic description. Biology of Blood & Marrow Transplantation 11(6):484-5, 2005.